Medical Technology

Abstract

This Program Element (PE) supports application of knowledge gained through basic research to refine drugs, vaccines, medical devices, diagnostics, medical practices/ procedures, and other preventive measures essential to the protection and sustainment of Warfighter health. Research is conducted in six principal areas: Combat Casualty Care, Military Operational Medicine, Military Relevant Infectious Diseases, Clinical and Rehabilitative Medicine, Medical Capabilities to Support Dispersed Operations, and Systems Biology/Network Sciences. Projects are coordinated with the Defense Health Agency. Project 874: Cbt Casualty Care Tech Description: Identifies and evaluates drugs, biologics (medical products derived from living organisms), medical devices, and associated clinical practices for field trauma care systems, resuscitation, and life support, with emphasis on provision of prolonged field care when medical evacuation and access to definitive surgical care are delayed. Focus is identification of more effective critical care technologies and clinical practices to treat severe bleeding, traumatic brain injury, burns and other combat related injuries. This Project is coordinated with the Defense Health Agency. Project MK4: Warfighter Health Applied Rsch Technology Description: Refines knowledge and technologies on screening tools and preventive measures for PTSD, behavioral health problems, and mild traumatic brain injuries, physiological monitors, and interventions to protect Warfighters from injuries resulting from operational stress and exposure to hazardous environments and materials. Also conducts research on medically valid testing devices and predictive models used for the refinement of Warfighter protective equipment. Project MM4 Cbt Casualty Care Applied Rsch Technology Description: Identifies and evaluates drugs, biologics (medical products derived from living organisms), medical devices and associated clinical practices for field trauma care, resuscitation, and life support with emphasis on provision of prolonged field care when medical evacuation and access to definitive surgical care is delayed. Focus is identification of more effective critical care technologies and clinical practices to treat severe bleeding, traumatic brain injury, burns and other combat related injuries. Project MM6: Medical Technologies to Support Dispersed Ops Technology Description: Medical Robotic and Autonomous Systems (Med-RAS) - Research to develop the ability to deliver emergency resupply of Medical material including repair parts peculiar to medical equipment by ground or air, such as blood products, and, utilization of autonomous platforms to perform medical treatment and medical evacuations in dispersed and multi-domain battle environments. Project MM8: Infectious Diseases Applied Rsch Technology Description: Applied research to design and refine drugs, vaccines, and other medical countermeasures against naturally occurring infectious diseases as identified by worldwide medical surveillance and capability needs assessments. Project MN1: Applied Sensory Systems Trauma Technology Description: Research to understand the influence of stress on the effectiveness of pain relief drugs (analgesics). This Project conducts laboratory and animal studies for the purpose of developing novel, non-opioid drugs to treat pain in the austere battlefield environment with minimal side effects. Project VB4: System Biology and Network Science Technology Description: Includes strategic oversight, direction and management of applied research in integrative systems biology of military relevant conditions, and the Systems Biology Collaboration Center (SBCC). The Sys Bio Cube (a biomedical research data integration and analysis system), managed by the SBCC, provides the ability for multi-site collaborative efforts to integrate, visualize and evaluate complex data using innovative technologies. Post-Traumatic Stress Disorder and coagulopathy (a disorder that impairs the blood's ability to form clots) projects have utilized the systems biology analytical tools and visualization within the Sys Bio Cube to inform the development of prognostic indicators, objective diagnostics, and improved and personalized therapeutic strategies more quickly than non-systems approaches. The SBCC also serves as a US Army Medical Research and Development Command (USAMRDC) resource for data sharing and data management for maximizing the value of all research efforts across the Command. The cited work is consistent with the Under Secretary of Defense for Research and Engineering science and technology focus areas and the Army Modernization Strategy. Work in this PE is performed by the United States Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD. All medical applied research is conducted in compliance with Food and Drug Administration (FDA) or Environmental Protection Agency (EPA) regulations. The FDA requires thorough testing in animals (preclinical testing) to ensure safety and, where possible, effectiveness prior to evaluation in controlled human clinical trials (upon transition to Advanced Technology Development). This PE focuses on research and refinement of technologies such as product formulation and purification and laboratory test refinement with the aim of identifying candidate solutions. This work often involves testing in animal models. The EPA also requires thorough testing of products, such as sterilants, disinfectants, repellents, and insecticides to ensure the environment is adequately protected before these products are licensed for use. Program refinement and execution is externally peer-reviewed and fully coordinated with all Services as well as other agencies through the Joint Technology Coordinating Groups of the Armed Services Biomedical Research Evaluation and Management (ASBREM) Community of Interest (COI). The ASBREM COI, formed under the authority of the Assistant Secretary of Defense for Research and Engineering, serves to facilitate coordination and prevent unnecessary duplication of effort within the Department of Defenses (DoD) biomedical research community, as well as their associated enabling research areas.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2022
Source ID
0602787A_2_2040_PB_2022
Change Summary Explanation
$7.000 million of FY22 will be realigned to APE 622787MM4 (Cbt Casualty Care Applied Rsch Technology) and $18.200 million of FY22-26 will be realigned to APE 622787MM8 (Infectious Diseases Applied Rsch Technology) from PE 0603002A (Medical Advanced Technology), APE 633002MM9( (Tech Base/Enabling Research for Infect Dis Adv Tech)
Service Agency Name
Army

Entities

Organizations

  • United States Army

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Brain Injuries
  • Combat Casualty Care
  • Combat Injuries
  • Debridement
  • Disability Administration
  • Health Services
  • Injury Prevention
  • Medical Personnel
  • Military Medicine
  • Unmanned Systems
  • Wounds And Injuries

Fields of Study

  • Medicine

Readers

  • Military Science and Technology Research and Modernization.
  • Neurotrauma and Rehabilitation Medicine.
  • Trauma or Military Medicine

Technology Areas

  • AI & ML
  • AI & ML - DoD AI Strategy
  • Autonomy
  • Biotechnology

Related Documents